Status:

COMPLETED

Evaluation of Efficacy and Comfort: A Trial on the Incrediwear Back Brace in Patients With Chronic Lower Back Pain

Lead Sponsor:

Johns Hopkins University

Conditions:

Low Back Pain

Back Pain

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The investigators hypothesize that the utilization of Incrediwear's Back Brace, compared to a sham brace and a standard-issue brace, will lead to better brace adherence, increased patient satisfaction...

Detailed Description

Problem: Chronic low back pain (LBP) affects a substantial portion of the population and often leads to decreased functional ability and increased pain medication usage. While back braces have been re...

Eligibility Criteria

Inclusion

  • Male or female, age \> 18
  • Has undergone treatment for an initial episode of nonspecific low back pain (LBP) lasting \> 1 month, with one of the following causative "Principle Diagnoses":
  • Disc herniation
  • Facet arthropathy
  • Compression fracture
  • Spondylolisthesis
  • Sacroiliac joint dysfunction
  • Scoliosis
  • Mild to moderate central spinal stenosis
  • Lumbar spondylosis
  • Degenerative changes, not otherwise specified
  • Utilize pain medication (including Step I or II analgesics, NSAIDs, Benzodiazepines) at least weekly for their LBP
  • Subject report a VAS pain score at the time of consent greater than three (\>3) out of ten (10)
  • Recommended a back brace for LBP management
  • Provide written consent for participation
  • Subject available for phone calls after 6PM

Exclusion

  • Severe central spinal stenosis
  • Focal lower extremity weakness
  • LBP radiating beyond the knee and/or accompanied by neurological signs (including sciatica)
  • Spinal operation within 5 years preceding the study date
  • Secondary LBP due to a work accident (e.g. workers comp)
  • History of spinal arthrodesis
  • LBP with an inflammatory, tumor, or infectious cause
  • Contraindications to: Step I or II analgesics, NSAIDs, Benzodiazepines
  • Diagnosed peripheral arterial disease
  • Diabetes
  • Higher functions do not enable proper comprehension of protocol or reliable data recording

Key Trial Info

Start Date :

January 9 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 30 2024

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT06126887

Start Date

January 9 2024

End Date

November 30 2024

Last Update

December 6 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Johns Hopkins Health Care & Surgery Center - Howard County Medical Center

Columbia, Maryland, United States, 21044